{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:05:07Z","timestamp":1791147907721,"version":"4.1.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1007\/bf02723096","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T08:57:25Z","timestamp":1201769845000},"page":"143-144","source":"Crossref","is-referenced-by-count":25,"title":["Miltefosine: An oral drug for visceral leishmaniasis"],"prefix":"10.1007","volume":"71","author":[{"given":"Rajniti","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. P.","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal Kant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02723096_CR1","doi-asserted-by":"crossref","unstructured":"Croft SL, Neal RA, Pendergast W, Chan JH. The activity of alkylphosphocholines and related deravatives against Leishmania donovani. Biochemical Parasitai 1987; 2633\u20132636.","DOI":"10.1016\/0006-2952(87)90543-0"},{"key":"BF02723096_CR2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","volume":"36","author":"A Kuhlencord","year":"1992","unstructured":"Kuhlencord A, Maniera T, Eibl H, Unger C. Hexadecyl Phosphocholine; oral treatment of visceral leishmaniasis in mice. Antimicrobial agents and Chemotherapy 1992; 36: 1630\u20131634.","journal-title":"Antimicrobial agents and Chemotherapy"},{"key":"BF02723096_CR3","first-page":"62","volume":"12","author":"D Bora","year":"1999","unstructured":"Bora D. Epidemiology of visceral leishmaniasis in India.Nat Med J India 1999; 12: 62\u201367.","journal-title":"Nat Med J India"},{"key":"BF02723096_CR4","unstructured":"Anon, 1998. Tropical Diseases Reaserch Progress 1997\u20131998, Fourteenth Programme Report \u2014 Leishmaniasis, PP. 1\u201322."},{"issue":"5","key":"BF02723096_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1568011033482341","volume":"3","author":"V Jendrossek","year":"2003","unstructured":"Jendrossek V, Handrick R. Mmebrane Targeted Anticancer Drugs: Potent Ihducer of Apoptosis and putative Radiosesis.Curr med Chem Anti-Cane Agents 2003; 3(5): 343\u2013353.","journal-title":"Curr med Chem Anti-Cane Agents"},{"key":"BF02723096_CR6","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","volume":"347","author":"S Sunder","year":"2002","unstructured":"Sunder S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J. Oral Miltefosine for Indian Visceral leishmaniasis.N Engl J Med 2002; 347: 1739\u20131746.","journal-title":"N Engl J Med"},{"issue":"2","key":"BF02723096_CR7","first-page":"1324","volume":"5","author":"PK Hanson","year":"2003","unstructured":"Hanson PK, Malone L, Birchmore JL, Nichols JW. Lern 3 p is essential for the uptake and potecy of alkylphosphocholine drugs, edelfosine and miltefosine.J Bid Chem 2003; 5(2): 1324\u20131331.","journal-title":"J Bid Chem"},{"key":"BF02723096_CR8","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","volume":"47","author":"FJ Perez-Victoria","year":"2003","unstructured":"Perez-Victoria FJ, Castanys S, Gamaroo F. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug. Antimicrobiol Agents Chemother. 2003; 47: 2397\u20132403.","journal-title":"Antimicrobiol Agents Chemother"},{"issue":"5","key":"BF02723096_CR9","first-page":"434","volume":"22","author":"S Sunder","year":"2003","unstructured":"Sunder S, Jha TK, Sindermann H, Bachmann P, Berman J. Oral miltefosine in children with mild to moderate Indian Visceral leishmanisis.Pediatr Infect Dis J 2003; 22(5): 434\u2013438.","journal-title":"Pediatr Infect Dis J"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02723096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02723096\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02723096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T01:48:54Z","timestamp":1558230534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02723096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["BF02723096"],"URL":"https:\/\/doi.org\/10.1007\/bf02723096","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}